Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Immunic, Inc.
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 4, 2026
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
May 4, 2026
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
May 1, 2026
Immunic to Participate in Investor Conferences in March
April 29, 2026
Immunic Announces Closing of Oversubscribed Private Placement Financing
March 10, 2026
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
March 10, 2026
←
Previous Page
1
2